Skip to main content

Advertisement

SpringerLink
Log in

Preeclampsia: Syndrome or Disease?

  • Preeclampsia (V Garovic, Section Editor)
  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

Abstract

The focus on disease mechanisms underlying the hypertension and proteinuria defining preeclampsia has increased knowledge of the pathophysiology yet we lack both therapy and predictors. We propose this is in part due to the fact that diagnostic findings identify a “preeclampsia syndrome” but do not necessarily indicate the most important pathophysiology nor if organs are involved as cause or consequence. The increased risk for later life cardiovascular disease in women who develop preeclampsia suggests the stress test of pregnancy exposes pre-existing subclinical vascular disease. The dogma that inadequate trophoblast invasion and ischemia/reperfusion injury to the placenta is “the” cause of preeclampsia is more relevant to early onset preeclampsia (<34 weeks). There is much less evidence for defective placentation in late onset preeclampsia where maternal constitutive factors or susceptibility to vascular damage is more relevant. The contribution of differing disease phenotypes to the syndrome may explain the inability of biomarker studies to identify all preeclampsia. Identification of phenotypes will require large amounts of prospective clinical data and biospecimens, collected in a harmonized manner with analysis in an unbiased discovery approach.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009;33(3):130–7. doi:10.1053/j.semperi.2009.02.010.

    Article  PubMed  Google Scholar 

  2. Ghulmiyyah L, Sibai B. Maternal mortality from preeclampsia/eclampsia. Semin Perinatol. 2012;36(1):56–9. doi:10.1053/j.semperi.2011.09.011.

    Article  PubMed  Google Scholar 

  3. Myatt L, Webster RP. Vascular biology of preeclampsia. J Thromb Haemost. 2009;7(3):375–84. doi:10.1111/j.1538-7836.2008.03259.x.

    Article  CAS  PubMed  Google Scholar 

  4. Williams D. Pregnancy: a stress test for life. Curr Opin Obstet Gynecol. 2003;15(6):465–71. doi:10.1097/01.gco.0000103846.69273.ba.

    Article  PubMed  Google Scholar 

  5. Caritis S, Sibai B, Hauth J, Lindheimer MD, Klebanoff M, Thom E, et al. Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med. 1998;338(11):701–5.

    Article  CAS  PubMed  Google Scholar 

  6. Roberts JM, Hubel CA. Pregnancy: a screening test for later life cardiovascular disease. Womens Health Issues. 2010;20(5):304–7. doi:10.1016/j.whi.2010.05.004.

    Article  PubMed  Google Scholar 

  7. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007;335(7627):974. doi:10.1136/bmj.39335.385301.BE.

    Article  PubMed Central  PubMed  Google Scholar 

  8. Powe CE, Levine RJ, Karumanchi SA. Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation. 2011;123(24):2856–69. doi:10.1161/CIRCULATIONAHA.109.853127.

    Article  PubMed  Google Scholar 

  9. Agatisa PK, Ness RB, Roberts JM, Costantino JP, Kuller LH, McLaughlin MK. Impairment of endothelial function in women with a history of preeclampsia: an indicator of cardiovascular risk. Am J Physiol Heart Circ Physiol. 2004;286(4):H1389–93.

    Article  CAS  PubMed  Google Scholar 

  10. Collen AC, Hellgren M, Gustafsson H, Johansson MC, Manhem K. Cardiovascular and metabolic characteristics 40 years after hypertensive pregnancies: a long-term follow-up study of mothers. J Hypertens. 2013;31(4):758–65.

    Article  CAS  PubMed  Google Scholar 

  11. Hubel CA, Wallukat G, Wolf M, Herse F, Rajakumar A, Roberts JM, et al. Agonistic angiotensin II type 1 receptor autoantibodies in postpartum women with a history of preeclampsia. Hypertension. 2007;49(3):612–7. doi:10.1161/01.HYP.0000256565.20983.d4.

    Article  CAS  PubMed  Google Scholar 

  12. Melchiorre K, Sutherland GR, Liberati M, Thilaganathan B. Preeclampsia is associated with persistent postpartum cardiovascular impairment. Hypertension. 2011;58(4):709–15.

    Article  CAS  PubMed  Google Scholar 

  13. Pouta A, Hartikainen A-L, Sovio U, Gissler M, Laitinen J, McCarthy MI, et al. Manifestations of metabolic syndrome after hypertensive pregnancy. Hypertension. 2004;43(4):825–31.

    Article  CAS  PubMed  Google Scholar 

  14. Wolf M, Hubel CA, Lam C, Sampson M, Ecker JL, Ness RB, et al. Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance. J Clin Endocrinol Metab. 2004;89(12):6239–43.

    Article  CAS  PubMed  Google Scholar 

  15. Catov JM, Parks WT, Roberts JM. Early pregnancy lipid and inflammatory markers in women with preterm premature rupture of membranes (PPROM) and preterm labor (PTL). Reprod Sci. 2010;17(3):389.

    Google Scholar 

  16. Catov JM, Wu CS, Olsen J, Sutton-Tyrrell K, Li J, Nohr EA. Early or recurrent preterm birth and maternal cardiovascular disease risk. Ann Epidemiol. 2010;20(8):604–9.

    Article  PubMed Central  PubMed  Google Scholar 

  17. Germain AM, Romanik MC, Guerra I, Solari S, Reyes MS, Johnson RJ, et al. Endothelial dysfunction: a link among preeclampsia, recurrent pregnancy loss, and future cardiovascular events?[see comment]. Hypertension. 2007;49(1):90–5.

    Article  CAS  PubMed  Google Scholar 

  18. Romundstad PR, Magnussen EB, Smith GD, Vatten LJ. Hypertension in pregnancy and later cardiovascular risk: common antecedents? Circulation. 2010;122(6):579–84. doi:10.1161/CIRCULATIONAHA.110.943407.

    Article  PubMed  Google Scholar 

  19. Brosens IA, Robertson WB, Dixon HG. The role of the spiral arteries in the pathogenesis of pre-eclampsia. J Pathol. 1970;101(4):Pvi.

    CAS  PubMed  Google Scholar 

  20. Huppertz B. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension. 2008;51(4):970–5. doi:10.1161/HYPERTENSIONAHA.107.107607.

    Article  CAS  PubMed  Google Scholar 

  21. Myatt L, Miodovnik M. Prediction of preeclampsia. Semin Perinatol. 1999;23(1):45–57.

    Article  CAS  PubMed  Google Scholar 

  22. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350(7):672–83.

    Article  CAS  PubMed  Google Scholar 

  23. Roberts JM, Hubel CA. The two stage model of preeclampsia: variations on the theme. Placenta. 2009;30(Suppl A):S32–7. doi:10.1016/j.placenta.2008.11.009.

    Article  PubMed Central  PubMed  Google Scholar 

  24. Chappell LC, Seed PT, Kelly FJ, Briley A, Hunt BJ, Charnock-Jones DS, et al. Vitamin C and E supplementation in women at risk of preeclampsia is associated with changes in indices of oxidative stress and placental function. Am J Obstet Gynecol. 2002;187(3):777–84.

    Article  CAS  PubMed  Google Scholar 

  25. Roberts JM, Myatt L, Spong CY, Thom EA, Hauth JC, Leveno KJ, et al. Vitamins C and E to prevent complications of pregnancy-associated hypertension. N Engl J Med. 2010;362:1282–91. doi:10.1056/NEJMoa0908056.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  26. Kenny LC, Black MA, Poston L, Taylor R, Myers JE, Baker PN, et al. Early pregnancy prediction of preeclampsia in nulliparous women, combining clinical risk and biomarkers: the screening for pregnancy endpoints (SCOPE) international cohort study. Hypertension. 2014;64(3):644–52. doi:10.1161/HYPERTENSIONAHA.114.03578. The largest prospective study to date fails to reveal a panel of biomarkers and clinical factors that has clinical utility in prediction of preeclampsia.

    Article  CAS  PubMed  Google Scholar 

  27. Myatt L, Clifton RG, Roberts JM, Spong CY, Hauth JC, Varner MW, et al. First-trimester prediction of preeclampsia in nulliparous women at low risk. Obstet Gynecol. 2012;119(6):1234–42. doi:10.1097/AOG.0b013e3182571669.

    Article  PubMed Central  PubMed  Google Scholar 

  28. Myatt L. Network. ftNM. Do women at high risk develop preeclampsia earlier in gestation than those at low risk? Am J Obstet Gynecol. 2001;184(Suppl):S81.

    Google Scholar 

  29. Myatt L. Network. ftNM. Differences in the time of diagnosis of mild vs severe preeclampsia between low and high risk patient groups. Hypertens Pregnancy. 2002;21 Suppl 1:63.

    Google Scholar 

  30. Roberts JM, Catov JM. Preeclampsia more than 1 disease: or is it? Hypertension. 2008;51(4):989–90. doi:10.1161/HYPERTENSIONAHA.107.100248.

    Article  CAS  PubMed  Google Scholar 

  31. Vatten LJ, Skjaerven R. Is pre-eclampsia more than one disease? BJOG. 2004;111(4):298–302.

    Article  PubMed  Google Scholar 

  32. Tranquilli AL, Brown MA, Zeeman GG, Dekker G, Sibai BM. The definition of severe and early-onset preeclampsia. Statements from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Pregnancy Hypertens. 2013;3(1):44–7. doi:10.1016/j.preghy.2012.11.001.

    PubMed  Google Scholar 

  33. Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. Br Med J. 2001;323(7323):1213–7.

    Article  CAS  Google Scholar 

  34. Mongraw-Chaffin ML, Cirillo PM, Cohn BA. Preeclampsia and cardiovascular disease death prospective evidence from the child health and development studies cohort. Hypertension. 2010;56(1):166–U264.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  35. Nelson DB, Ziadie MS, McIntire DD, Rogers BB, Leveno KJ. Placental pathology suggesting that preeclampsia is more than one disease. Am J Obstet Gynecol. 2014;210(1):66 e1–7. doi:10.1016/j.ajog.2013.09.010.

    Article  PubMed  Google Scholar 

  36. Stark MW, Clark L, Craver RD. Histologic differences in placentas of preeclamptic/eclamptic gestations by birthweight, placental weight, and time of onset. Pediatr Dev Pathol. 2014;17(3):181–9. doi:10.2350/13-09-1378-OA.1.

    Article  PubMed  Google Scholar 

  37. Eskild A, Vatten LJ. Do pregnancies with pre-eclampsia have smaller placentas? A population study of 317 688 pregnancies with and without growth restriction in the offspring. BJOG. 2010;117(12):1521–6. doi:10.1111/j.1471-0528.2010.02701.x.

    Article  CAS  PubMed  Google Scholar 

  38. Poon LC, Kametas NA, Maiz N, Akolekar R, Nicolaides KH. First-trimester prediction of hypertensive disorders in pregnancy. Hypertension. 2009;53(5):812–8. doi:10.1161/HYPERTENSIONAHA.108.127977.

    Article  CAS  PubMed  Google Scholar 

  39. Roberts JM. Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol. 1998;16(1):5–15.

    Article  CAS  PubMed  Google Scholar 

  40. Khan F, Belch JJ, MacLeod M, Mires G. Changes in endothelial function precede the clinical disease in women in whom preeclampsia develops. Hypertension. 2005;46(5):1123–8. doi:10.1161/01.HYP.0000186328.90667.95.

    Article  CAS  PubMed  Google Scholar 

  41. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol. 1989;161(5):1200–4.

    Article  CAS  PubMed  Google Scholar 

  42. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111(5):649–58.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  43. Karumanchi SA, Bdolah Y. Hypoxia and sFlt-1 in preeclampsia: the “chicken-and-egg” question. Endocrinology. 2004;145(11):4835–7.

    Article  CAS  PubMed  Google Scholar 

  44. Powers RW, Roberts JM, Plymire DA, Pucci D, Datwyler SA, Laird DM, et al. Low placental growth factor across pregnancy identifies a subset of women with preterm preeclampsia: type 1 versus type 2 preeclampsia? Hypertension. 2012;60(1):239–46. doi:10.1161/HYPERTENSIONAHA.112.191213. This paper shows that low PlGF is not common to all pregnancies with preeclampsia and reveals different phenotypes based on PLGF levels.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  45. Wallner W, Sengenberger R, Strick R, Strissel PL, Meurer B, Beckmann MW, et al. Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction. Clin Sci (Lond). 2007;112(1):51–7. doi:10.1042/CS20060161.

    Article  CAS  Google Scholar 

  46. Dekker GA, Sibai BM. The immunology of preeclampsia. Semin Perinatol. 1999;23(1):24–33.

    Article  CAS  PubMed  Google Scholar 

  47. Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol. 1999;180(2 Pt 1):499–506.

    Article  CAS  PubMed  Google Scholar 

  48. Seely EW, Solomon CG. Insulin resistance and its potential role in pregnancy-induced hypertension. J Clin Endocrinol Metab. 2003;88(6):2393–8.

    Article  CAS  PubMed  Google Scholar 

  49. Founds SA, Catov JM, Gallaher MJ, Harger GF, Markovic N, Roberts JM. Is there evidence of separate inflammatory or metabolic forms of preeclampsia? Hypertens Pregnancy. 2011;30(1):1–10. doi:10.3109/10641950903322907.

    Article  PubMed Central  PubMed  Google Scholar 

  50. Leijnse J, de Heus R, Peeters L, Oudijk M, Franx A, Eijkelkamp N. Poor placental vascularization at 12 weeks of pregnancy is associated with a specific cluster of serum proteins. Reprod Sci. 2015;22(S1):69A.

    Google Scholar 

  51. Johnson MP, Brennecke SP, East CE, Goring HH, Kent Jr JW, Dyer TD, et al. Genome-wide association scan identifies a risk locus for preeclampsia on 2q14, near the inhibin, beta B gene. PLoS One. 2012;7(3), e33666. doi:10.1371/journal.pone.0033666.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  52. Laivuori H, Lahermo P, Ollikainen V, Widen E, Haiva-Mallinen L, Sundstrom H, et al. Susceptibility loci for preeclampsia on chromosomes 2p25 and 9p13 in Finnish families. Am J Hum Genet. 2003;72(1):168–77.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  53. Founds SA, Conley YP, Lyons-Weiler JF, Jeyabalan A, Hogge WA, Conrad KP. Altered global gene expression in first trimester placentas of women destined to develop preeclampsia. Placenta. 2009;30(1):15–24. doi:10.1016/j.placenta.2008.09.015.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  54. Kleinrouweler CE, van Uitert M, Moerland PD, Ris-Stalpers C, van der Post JA, Afink GB. Differentially expressed genes in the pre-eclamptic placenta: a systematic review and meta-analysis. PLoS One. 2013;8(7), e68991. doi:10.1371/journal.pone.0068991.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  55. Loset M, Mundal SB, Johnson MP, Fenstad MH, Freed KA, Lian IA, et al. A transcriptional profile of the decidua in preeclampsia. Am J Obstet Gynecol. 2011;204(1):84 e1–27. doi:10.1016/j.ajog.2010.08.043.

    Article  PubMed  Google Scholar 

  56. Winn VD, Gormley M, Paquet AC, Kjaer-Sorensen K, Kramer A, Rumer KK, et al. Severe preeclampsia-related changes in gene expression at the maternal-fetal interface include sialic acid-binding immunoglobulin-like lectin-6 and pappalysin-2. Endocrinology. 2009;150(1):452–62. doi:10.1210/en.2008-0990.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  57. Yong HE, Melton PE, Johnson MP, Freed KA, Kalionis B, Murthi P, et al. [81-OR]: genome-wide transcriptome directed pathway analysis of maternal preeclampsia susceptibility genes. Hypertens Pregnancy. 2015;5(1):43–4. doi:10.1016/j.preghy.2014.10.085.

    Google Scholar 

  58. Leavey K, Bainbridge SA, Cox BJ. Large scale aggregate microarray analysis reveals three distinct molecular subclasses of human preeclampsia. PLoS One. ;10(2):e0116508. doi:10.1371/journal.pone.0116508. An analysis of 7 placental microarray datasets revealed 3 distinct phenotypes of preeclampsia defined by differences in placental gene expression.

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Drs. Myatt and Roberts declare no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. Center for Pregnancy and Newborn Research, Department of Obstetrics and Gynecology, University of Texas Health Science Center San Antonio, 7703 Floyd Curl Drive, San Antonio, TX, 78229-3900, USA

    Leslie Myatt

  2. Magee-Women’s Research Institute, Department of Obstetrics and Gynecology and Reproductive Sciences, Epidemiology and Clinical and Translational Research, University of Pittsburgh, 204 Craft Avenue, Pittsburgh, PA, 15213, USA

    James M. Roberts

Authors
  1. Leslie Myatt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. James M. Roberts
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Leslie Myatt.

Additional information

This article is part of the Topical Collection on Preeclampsia

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Myatt, L., Roberts, J.M. Preeclampsia: Syndrome or Disease?. Curr Hypertens Rep 17, 83 (2015). https://doi.org/10.1007/s11906-015-0595-4

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11906-015-0595-4

Keywords

Search

Navigation